There is no long-term, randomized, outcome-based human trial demonstrating that GHRP-2 slows aging or produces durable benefit in healthy people
Citations Citations to this article as recorded by Beyond Cyclic Nucleotides: Emerging Roles of Phosphodiesterases in Metabolic Disorders Nicole Bertani, Maria Rita Assenza, Francesca Sciarra, Giorgia DAddato, Francesca Gioia Klinger, Mary Anna Venneri, Andrea M
DAMPs also impact Kupffer cells, activating the nucleotide-binding oligomerization domain-like receptor (NLR) Family, Pyrin Domain-Containing 3 protein (NLRP3), a type of inflammasome leading to IL-1 secretion and inflammation, and pyroptosis, releasing more DAMPs and perpetuating a destructive cycle (Hammerich and Tacke, 2023)
Sleep changes (if present) tend to stabilize